HITV Lab

Call Us : +603-9010-3058
Email Us : This email address is being protected from spambots. You need JavaScript enabled to view it.

Tuesday22 August 2017

Bernama : Cancer Cure Is Now In Malaysia

Bernama

KUALA LUMPUR, Oct 24 (Bernama) -- There is a new hope for cancer patients in Malaysia.

A vaccine widely known for treating late-stage cancer -- almost all types of cancer, except leukemia -- is now available in the country.

The Human Initiated Therapeutic Vaccine (HITV), which was only available in Japan previously, is able to completely destroy microscopic and tiny nests of cancer cells, thus preventing any future recurrences.

Discovered in 2005 by Dr Kenichiro Hasumi, a Japanese physician and researcher, HITV is an autologus (patient derived) active cell-based immunotherapy for metastatic or late-stage cancer patients.

Read more ...

星洲日報:人類首創治療性疫苗

health sinchew-i

(吉隆坡24日訊)人類首創治療性疫苗(HITV)癌症治療法,成功為患上第四期肺癌的病患吳世華帶來新希望。

現年58歲的吳世華今日在“癌症病患新希望”的分享會上表示,她是透過馬哈美魯國際醫藥中心(Mahameru International Medical Centre)馬楚欽醫生的介紹,向蓮見國際研究財團創辦人兼主席蓮見賢一郎醫生求醫,並接受人類首創治療性疫苗的資料。

“當我在東京的時候,我躺在床上10個小時,他為我注射約40針。這真的很驚人,因為我還能坐起來和上廁所。”

6星期後癌細胞已消失

在6個星期後,她體內所有的癌細胞幾乎都已經消失了。目前她也繼續接受有關治療,以抵抗殘留在她體內的癌細胞。

Read more ...

Subcategories

HITV Lab

HITV Lab is involved in cell-based biotechnology medical applications with special focus on Dendritic Cell-Based Immunotherapy for cancer. HITV Lab is committed to support an international collaboration in the FDA clinical trial of HITV Therapy in late-stage cancer patients led by the University of Maryland, USA.

FacebookTwitterGoogle Bookmarks